Galectin Therapeutics Inc.
GALT
$4.05
-$0.09-2.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.27M | 14.11M | 17.72M | 11.53M | 13.77M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.39M | 1.58M | 1.71M | 1.20M | 1.66M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 6.00K | -- | -- |
| Total Current Assets | 14.66M | 15.69M | 19.44M | 12.73M | 15.43M |
|
|
|||||
| Total Current Assets | 14.66M | 15.69M | 19.44M | 12.73M | 15.43M |
| Net Property, Plant & Equipment | 118.00K | -- | 22.00K | 37.00K | 100.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 49.00K | 68.00K | 74.00K | 99.00K | 174.90K |
| Total Assets | 14.83M | 15.76M | 19.53M | 12.87M | 15.60M |
|
|
|||||
| Total Accounts Payable | 3.73M | 3.12M | 3.25M | 5.39M | 5.87M |
| Total Accrued Expenses | 3.93M | 4.18M | 4.70M | 5.00M | 4.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 143.90M | 6.00K | 22.00K | 126.05M | 52.00K |
| Total Finance Division Other Current Liabilities | 62.00K | -- | 63.00K | -- | 63.00K |
| Total Other Current Liabilities | 62.00K | -- | 63.00K | -- | 63.00K |
| Total Current Liabilities | 151.62M | 7.31M | 8.03M | 136.45M | 10.77M |
|
|
|||||
| Total Current Liabilities | 151.62M | 7.31M | 8.03M | 136.45M | 10.77M |
| Long-Term Debt | -- | 138.69M | 137.70M | -- | 122.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 59.00K | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 151.68M | 146.00M | 145.73M | 136.45M | 132.77M |
|
|
|||||
| Common Stock & APIC | 307.73M | 305.17M | 304.14M | 301.19M | 299.38M |
| Retained Earnings | -446.79M | -437.61M | -432.55M | -426.98M | -418.76M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -139.06M | -132.44M | -128.41M | -125.79M | -119.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.20M | 2.20M | 2.21M | 2.21M | 2.21M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.20M | 2.20M | 2.21M | 2.21M | 2.21M |
|
|
|||||
| Total Common Equity | -139.06M | -132.44M | -128.41M | -125.79M | -119.38M |
| Total Preferred Equity | 2.20M | 2.20M | 2.21M | 2.21M | 2.21M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -136.85M | -130.24M | -126.20M | -123.58M | -117.17M |
|
|
|||||